Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy

Overview of attention for article published in Patient preference and adherence, November 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 23 publications that cite this research output.

23

The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.

Evaluating the Efficacy of Carmustine Combined with Temozolomide in the Treatment of Glioma Following Minimally Invasive Surgery

Article in International Journal of Pharmacology (November 2023)

Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma

Article in Polymers (October 2023)

Miniaturized neural implants for localized and controllable drug delivery in the brain

Article in Journal of Materials Chemistry B (July 2023)